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INTRODUCTION
In general, protein conformational changes are best
studied in the appropriate native environment, whether
it be aqueous solution or a biological membrane. 19F
nuclear magnetic resonance (NMR) provides a valuable
tool with which to carry out such studies, even for a
variety of proteins too large or insoluble for multidimen-
sional NMR techniques. Recombinant DNA techniques
significantly extend the usefulness of 19F NMR, both by
facilitating resonance assignments, and by enabling
separation of multidomain structures into smaller, more
accessible units. The present study illustrates the type of
information provided by this combined approach using
two receptors from the E. coli chemosensory pathway as
examples: the periplasmic o-galactose and o-glucose
receptor and the transmembrane aspartate transducer.
THE 19F NMR METHOD
The usefulness of 19F NMR stems from several unique
features of the 19F nucleus. This spin one-half nucleus
exhibits high sensitivity (0.94 relative to 'H) and a
relatively large frequency range (Hf-fold larger than
'H). The 19F NMR frequency is controlled largely by the
fluorine lone-pair electrons, which provide a large anti-
diamagnetic term in the shielding formula. As a result
the NMR frequency is exquisitely sensitive to changes in
the van der Waals packing around the nucleus, whereas
aromatic f1uorines are further sensitive to changes in the
electron distribution of the adjacent 'IT system. Proteins
expressed in E. coli can be routinely fluorine labeled by
biosynthetic incorporation of tryptophan, phenylala-
nine, or tyrosine substituted at one ring position with
fluorine. A number of studies have shown that the
effects of such "single atom mutagenesis" on protein
structure and activity are generally small or undetect-
able (reviewed in references 1-5). When biosynthetic
labeling is impractical, alkylation of cysteine or lysine
with a fluorine-labeled reagent provides another incorpo-
ration method (6,7).
RESULTS AND DISCUSSION
D-galactose and D-glucose receptor
The o-galactose and o-glucose receptor is a 32 kDa
periplasmic binding protein whose function is to seques-
ter a sugar molecule, then dock to and activate one of
two proteins spanning the cytoplasmic membrane: a
sugar transporter or a sensory transducer. The structure
of the receptor containing bound o-glucose has been
solved to 1.9 A resolution, and the protein is known to
undergo a large conformational change upon glucose
binding in solution (8, 9). The crystal structure reveals
two domains, each composed of an a/13 motif, connected
by three strands of polypeptide proposed to comprise a
flexible hinge. The bound sugar molecule is trapped in
the closed cleft between the two domains. A plausible
model for the conformational change proposes that
bound sugar stabilizes the closed cleft, whereas the
empty cleft has, on average, a more open conformation
(9).
To test this model, we have biosynthetically incorpo-
rated 5-f1uorotryptophan (5F-trp) into the five tryp-
tophan positions of the receptor (65 ± 10% incorpora-
tion). In separate experiments, 3-fluorophenylalanine
(3F-phe) has been incorporated into the seven phenyla-
lanine positions (20 ± 10% incorporation). Fig. 1 shows
the positions of the labeled residues. Trp 183 and phe 16
are in van der Waals contact with bound sugar, yet the
fluorine-containing molecules in the labeled population
are observed to have o-galactose affinities only slightly
lower than that of the unlabeled molecule: 2.2- to
3.0-fold lower for 5F-trp, and 1.5- to 4.0-fold lower for
3F-phe. The receptor also possesses an EF-handlike
Ca(II) binding site: fluorine labeling causes still smaller
perturbations at this site (3).
The 5F-trp resonances were assigned by use of oligo-
nucleotide-directed mutagenesis to replace a single
tryptophan with tyrosine (or in one case, phenylalanine),
thereby eliminating the associated resonance from the
19F NMR spectrum. Fig. 2 illustrates the assigned spec-
tra for the sugar-empty and sugar-occupied conformers.
The 5F-trp 127 and 133 residues give rise to double
resonances, indicating two stable structures in this
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FIGURE 1 Stereo a-carbon backbone structure of the E. coli o-galac-
tose and o-g1ucose receptor (8). The solid ring indicates the bound
o-glucose molecule in the sugar cleft, and the cross denotes the Ca(lI)
ion in the metal site. Also shown are the five trp and seven phe
positions which serve as '''F-Iabeling sites.
region on the NMR timescale (7 ms), perhaps due to
cis-trans isomerization of nearby proline 231. This struc-
tural heterogeneity is highly localized because it causes
no detectable effects within the sugar and Ca(II) sites
(3).
A simple test of the hinged cleft model is to monitor
the solution exposure of 5F-trp 183, which is seques-
tered in the closed cleft, but should become accessible to
the bulk solution if the cleft opens substantially. The
trivalent lanthanide Gd(III) (S = 7/2) is a suitable
paramagnetic probe for this purpose because it signifi-
cantly broadens the NMR resonance of a nucleus it
approaches, in proportion to the inverse sixth power of
the separation (r):
~~'/2 = r-6b:i~2S(S + 1)][4'Tc + 3'Tc/(1 + w:'T~)]/(15 'IT'). (1)
Here AAII2 is the paramagnetic linebroadening, "VI is the
magnetogyric ratio for the nuclear spin, g is the Lande
g-factor for a free electron spin, 13 is the Bohr magneton,
WI is the nuclear resonance frequency in radians s-1, and
the correlation time Tc of this magnetic dipole-dipole
interaction contains contributions from the electron
spin-lattice relaxation, the rotation of the interdipole
A
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FIGURE 2 470 MHz 19F NMR spectra of the o-galactose and o-glucose receptor. (A) Effect of Gd(III) . EDTA-on the 5F-trp labeled receptor in
the absence of sugar. (Upper traces) no Gd(III) . EDTA- (Lower traces) 5.6 mM Gd(III) . EDTA-. (B) Effect of o-galactose on the 5F-trp labeled
receptor. (Upper traces) no sugar. (Lower traces) 1.0 mM o-galactose. A and B) Spectra were obtained at 25° on a Varian VXR500. Samples
contained: 100mM KCI, 10 mM pH 7.1 Tris, 0.5-5.0 mM CaCI2, 10% D,0 for lock, and 75 ILM 3F-phe as an internal frequency reference. Modified
from references 3 and 5.
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FIGURE 3 Schematic hinged-cleft of the o-galactose and o-glucose
receptor. Dimensions are from the known structure of the closed cleft
(8); the unhydrated diameter of the paramagnetic probe Gd(III) .
EDTA- is 10 A (5). (A) The lOF NMR data indicate that the distance
of closest approach between the probe and the observe lOF nucleus
(5F-trp 183, F) is r ~ 15 A in the sugar occupied cleft. (B) In the empty
cleft the distance of closest approach is r ::; 10 A, requiring the cleft to
open by an angle of 6 ~ 18° to accomodate the probe. Modified from
reference five.
vector, and the exchange time of the paramagnet in the
site. In the present application the probe complex
Gd(III) . EDTA-is used for its large size (least squares
diameter = 9.7 A), to ensure that the paramagnet can-
not enter the closed cleft.
Fig.2A illustrates the dramatic broadening of the
5F-trp 183 resonance caused by addition of Gd(III) .
EDTA-to the empty cleft. The broadening of this
resonance is more than twofold larger than any other, and
increases linearly with the probe concentration, such
that aal/2 = 130 ± 10 Hz when [Gd(III) . EDTA-] = 9.3
mM. In contrast, as predicted by the crystal structure, no
broadening of the 5F-trp 183 resonance is observed in
the presence of 1.0 mM D-glucose, indicating that the
sugar-occupied cleft remains closed, on average, in
solution (5). These results confirm the predictions of the
hinged-cleft model, and enable calculation of the angle
of cleft opening. Using the model cleft illustrated in
Fig. 3, together with Eq. 1 and the appropriate constants
(5), the distance of closest approach of the probe
complex to the nucleus is found to be r ~ 10 A. For the
The transmembrane aspartate
transducer
probe to penetrate this deeply into the protein, the cleft
must open ~ 18°.
A key question is whether this large hinged cleft
motion perturbs the structure of the two domains.
Alternatively, the domains could move as rigid bodies.
This issue is central to receptor function because activa-
tion of the receptor must produce surface structure
changes, which in turn regulate receptor docking to its
target protein. To address this question, the effect of
sugar binding on the 12 NMR positions in the receptor
has been tested. Examination of the 19F NMR frequen-
cies of the five 5F-trp residues and seven 3F-phe
residues indicates that 9/12 of these positions in the
structure are perturbed by sugar binding, whereas 3/12
are not perturbed (3). For example, Fig. 2 B illustrates
the frequency shifts observed for the 5F-trp 183, 195,
and 284 resonances; the latter two residues are distant
from the sugar cleft. Together the data indicate that
sugar binding triggers widespread structural changes in
both domains. The only region unaffected is the Ca(II)
site, which appears to be conformationally isolated from
the rest of the receptor (4).
In short, the o-galactose and o-glucose receptor
possesses a hinged substrate cleft which regulates an
allosteric structural change in most regions of the
molecule. Examination of the backbone structure sug-
gests a simple mechanism for this allostery. Sixteen
secondary structure elements terminate in the cleft (8
a-helices and 8 J3-strands), and the closing of the cleft
will shift many of these elements. The resulting small
movements will be transmitted along the entire length of
each perturbed element, out to the protein surface. (For
a full account of these 19F NMR studies of the o-galac-
tose and o-glucose receptor, see references 3-5).
The aspartate transducer is a transmembrane ho-
modimer of 60 kD monomers. Fig. 4 presents a hypothet-
ical structure consistent with the available biochemical
and structural evidence (10-12, 15). This receptor is
activated by aspartate binding to its periplasmic domain,
which in turn induces a transmembrane conformational
change that regulates the cytoplasmic signaling domain.
The transducer appears to be mechanistically related to
a large class of eukaryotic receptors for insulin, EGF
and other growth hormones; thus, when the kinase
domain of the human insulin receptor is substituted for
the cytoplasmic signaling domain, the resulting chimera
is an aspartate-activated kinase (13).
A large, membrane-bound protein is often considered
inaccessible to solution NMR techniques because the
B
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FIGURE 4 Hypothetical structure of the transmembrane aspartate
transducer of E. coli (10--12,15). Shown are the three domains of each
monomer in the homodimer, each proposed to be dominated by
a-helices. (Upper) the periplasmic aspartate binding domain of each
monomer is a four-helix bundle. (Middle) the two predicted transmem-
brane helices of each monomer. (Lower) the signaling domain, which
activates the cytoplasmic phosphorylation pathway.
slow molecular tumbling will yield large spin-spin relax-
ation rates for most protein nuclei, such that the
associated resonances are too broad to detect. However,
if a probe nucleus is placed at a site which experiences
sufficiently rapid and isotropic local motion, its NMR
resonance can be detected irregardless of the molecular
size.
To demonstrate this approach, we have biosyntheti-
cally incorporated 5F-trp into the intact transducer in
the native, isolated membrane (mol wt > 106 kD per
membrane), as well as the transducer's water soluble
cytoplasmic domain (mol wt = 64 kD per homodimer).
(Plasmids overexpressing each E. coli protein were
graciously provided by Dr. M. Simon, Caltech [14]). The
full-length transducer monomer contains four tryp-
tophans, whereas the cytoplasmic domain contains one.
The 19F NMR spectrum of the water-soluble cytoplas-
mic fragment is shown in Fig. 5 A, revealing a single
sharp resonance for 5F-trp 550, which lies just three
FIGURE 5 470 MHz '''F NMR spectra of the 5F-trp labeled aspartate
transducer. (A) Spectrum of the isolated cytoplasmic domain, showing
the 5F-trp 550 resonance. (B) Spectra of the full-length transducer in
the isolated native membrane, illustrating the frequency shift induced
by aspartate binding (bold spectrum). Spectra were obtained at 25°.
Samples contained: 50 mM NaCI, 20 mM pH 8.0 Tris, 10% glycerol,
10% D,o for lock, and 50 ILM 3F-phe as an internal frequency
reference.
residues from the COOH-tenninus. This result indicates
that the two monomers within the dimer are equivalent,
and suggests that the 5F-trp probe has significant local
mobility on the relevant NMR timescale (10-7 s). Addi-
tional evidence for this picture is provided by the 19F
NMR spectrum of the full-length, membrane-bound
transducer (Fig. 5 B). A single sharp resonance is again
observed, presumed to be from the same 5F-trp 550
position in the COOH-tenninal region, whereas the
other three tryptophan positions are rendered invisible
by the slow tumbling of the transducer-membrane com-
plex. No resonances are observed for otherwise identical
membranes lacking the transducer. When aspartate is
added to generate the activated confonnation, the
resulting transmembrane confonnational change yields
detectable NMR frequency shift at the probe position
(Fig. 5 B).
Together these results suggest that the I~ NMR
approach can be applied even to large, relatively immo-
bile macromolecular systems. When extending this ap-
proach to a particular system of interest, the key
challenge is to find suitable labeling sites which provide
the needed local mobility. One approach which appears
particularly promising is the chemical labeling of engi-
neered surface cysteine residues.
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